Day: October 21, 2021

Smart Sand, Inc. Announces Timing of Third Quarter 2021 Earnings Release and Investor Conference Call

Smart Sand, Inc. Announces Timing of Third Quarter 2021 Earnings Release and Investor Conference Call

THE WOODLANDS, Texas, Oct. 21, 2021 (GLOBE NEWSWIRE) — Smart Sand, Inc. (NASDAQ: SND) (the “Company”) announced today that it will release its third quarter financial results after the market closes on Tuesday, November 9, 2021. The Company will hold a conference call for investors on Wednesday, November 10, 2021 at 10:00 a.m. Eastern Time to discuss recent events and the results. Chuck Young, the Company’s chief executive officer, Lee Beckelman, the Company’s chief financial officer and John Young, the Company’s chief operating officer, will host the call. Investors are invited to listen to a live webcast of the conference call by visiting the “Investors” section of the Company’s website at www.smartsand.com. The call can also be accessed live over the telephone by dialing (888) 799-5165 or for international callers, (478) 219-0056....

Continue reading

Babylon Closes Business Combination and Will Begin Trading on the New York Stock Exchange Under the Ticker BBLN

Babylon Closes Business Combination and Will Begin Trading on the New York Stock Exchange Under the Ticker BBLN

Kinnevik AB (publ) (“Kinnevik”) today announced that Babylon it has completed its business combination with Alkuri Global Acquisition Corp, a special purpose acquisition company. The transaction was approved on October 20, 2021 by Alkuri’s shareholders. Babylon’s shares of Class A common stock and its warrants will begin trading on the New York Stock Exchange (“NYSE”) on October 22, 2021 under the new ticker symbols “BBLN” and “BBLN.W”, respectively. After the closing of the transaction, Kinnevik will hold 54,240,640 A shares in the company. For full information from the company, please see https://www.babylonhealth.com/press/press-room Georgi Ganev, CEO of Kinnevik commented: “We continue to be impressed by the founder and CEO of Babylon Health, Ali Parsa’s and his team’s dedication to provide affordable, accessible and data-driven...

Continue reading

Glacier Bancorp, Inc. Announces Results For The Quarter And Period Ended September 30, 2021

Glacier Bancorp, Inc. Announces Results For The Quarter And Period Ended September 30, 2021

3rd Quarter 2021 Highlights: The loan portfolio, excluding the Payroll Protection Program (“PPP”) loans, increased $382 million, or 14 percent annualized, in the current quarter. Core deposits increased $742 million, or 18 percent annualized, during the current quarter. Net interest income (tax-equivalent), excluding the PPP loans, of $154 million, increased $4.6 million, or 3 percent, over the prior quarter net interest income of $150 million. Received $327 million in PPP loan forgiveness proceeds from the U.S. Small Business Administration (“SBA”) during the current quarter compared to $350 million in the prior quarter. Declared a quarterly dividend of $0.32 per share. The Company has declared 146 consecutive quarterly dividends and has increased the dividend 48 times. Completed the acquisition of Altabancorp, the parent company of...

Continue reading

Altus and EagleClaw Announce All-Stock Business Combination; Creates a Leading Pure-Play Permian Integrated Midstream Company With a Capital Return Focus

Altus and EagleClaw Announce All-Stock Business Combination; Creates a Leading Pure-Play Permian Integrated Midstream Company With a Capital Return Focus

Combination forms the largest integrated midstream company in the Delaware Basin with an estimated enterprise value today of $9 billion The combined company generates a balanced mix of earnings from midstream gathering and processing and long-haul pipeline transportation, representing approximately 65% and 35% of 2022 estimated EBITDA, respectively Operates approximately 2 Bcf per day of newly constructed cryogenic natural gas processing facilities in the Delaware Basin with more than 850,000 acres under fee-based, long-term dedications for midstream activities Premier portfolio of interests in four newly built, long-term contracted pipelines transporting natural gas, NGLs, and crude oil from the Permian Basin to the Gulf Coast Diverse, high-quality customer base with over 30 primarily investment grade counterparties Complementary...

Continue reading

Bryn Mawr Bank Corporation Reports Quarterly Earnings of $18.4 Million, Declares $0.28 Dividend

Bryn Mawr Bank Corporation Reports Quarterly Earnings of $18.4 Million, Declares $0.28 Dividend

BRYN MAWR, Pa., Oct. 21, 2021 (GLOBE NEWSWIRE) — Bryn Mawr Bank Corporation (NASDAQ: BMTC) (the “Corporation”), parent of The Bryn Mawr Trust Company (the “Bank”), today reported net income of $18.4 million, or $0.92 diluted earnings per share, for the three months ended September 30, 2021, as compared to $21.3 million, or $1.06 diluted earnings per share, for the three months ended June 30, 2021, and $13.2 million, or $0.66 diluted earnings per share, for the three months ended September 30, 2020. On a non-GAAP basis, core net income, which excludes due diligence and merger-related expenses related to the pending merger with WSFS Financial Corporation (“WSFS”) and other non-core income and expense items, as detailed in the appendix to this earnings release, was $18.0 million, or $0.90 diluted earnings per share, for the three...

Continue reading

Enterprise Bancorp, Inc. Announces Third Quarter Financial Results

Enterprise Bancorp, Inc. Announces Third Quarter Financial Results

LOWELL, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — Enterprise Bancorp, Inc. (NASDAQ: EBTC), parent of Enterprise Bank, announced net income for the three months ended September 30, 2021 of $9.8 million, or $0.81 per diluted common share, compared to $10.3 million, or $0.87 per diluted common share, for the three months ended September 30, 2020. Net income for the nine months ended September 30, 2021 amounted to $31.3 million, or $2.60 per diluted common share, compared to $21.6 million, or $1.81 per diluted common share, for the nine months ended September 30, 2020. As previously announced on October 19, 2021, the Company declared a quarterly dividend of $0.185 per common share to be paid on December 1, 2021 to shareholders of record as of November 10, 2021. Chief Executive Officer Jack Clancy commented, “I am pleased to report our...

Continue reading

European Wax Center, Inc. to Report Third Quarter 2021 Financial Results on November 4th

European Wax Center, Inc. to Report Third Quarter 2021 Financial Results on November 4th

PLANO, Texas, Oct. 21, 2021 (GLOBE NEWSWIRE) — European Wax Center (NASDAQ: EWCZ), a leading personal care franchise brand offering expert wax services, today announced that it will report third quarter fiscal 2021 earnings results after the market closes on Thursday, November 4th, 2021. The company will host an investor conference call and webcast to review third quarter financial results at 5:00pm ET/4:00pm CT on the same day. The webcast can be accessed at https://investors.waxcenter.com. The conference call can be accessed by calling (844) 644-2466 (participant passcode 3947568). International callers may dial (918) 922-6900. A replay of the webcast will remain available on the website for 90 days. A replay of the conference call will be available until 8:00pm ET on November 10, 2021 and can be accessed by dialing (855) 859-2056...

Continue reading

Lumos Pharma to Report Third Quarter 2021 Financial Results and Host Conference Call on November 3, 2021

Lumos Pharma to Report Third Quarter 2021 Financial Results and Host Conference Call on November 3, 2021

AUSTIN, Texas, Oct. 21, 2021 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced it will report its third quarter 2021 financial results after market close on Wednesday, November 3, 2021. The company will host a conference call and webcast at 4:30 PM ET that day to discuss these financial results and provide an update on clinical and corporate activities. There will be a question-and-answer session following the prepared remarks. Investors and the general public are invited to listen to a live audio webcast of the conference call, which may be accessed five minutes prior to the start of the call by dialing (855) 469-0612 (U.S.) or (484) 756-4268 (international) or through the link, https://edge.media-server.com/mmc/p/yxhoo2hz....

Continue reading

Meridian Bancorp, Inc. Announces Results for the Quarter and Nine Months Ended September 30, 2021

Meridian Bancorp, Inc. Announces Results for the Quarter and Nine Months Ended September 30, 2021

BOSTON, Oct. 21, 2021 (GLOBE NEWSWIRE) — Meridian Bancorp, Inc. (the “Company” or “Meridian”) (NASDAQ: EBSB), the holding company for East Boston Savings Bank (the “Bank”), announced net income of $18.3 million, or $0.36 per diluted share, for the quarter ended September 30, 2021, compared to $16.5 million, or $0.32 per diluted share for the quarter ended June 30, 2021, and $16.7 million, or $0.33 per diluted share, for the quarter ended September 30, 2020. For the nine months ended September 30, 2021, net income was $59.2 million, or $1.17 per diluted share, up from $46.9 million, or $0.93 per diluted share, for the nine months ended September 30, 2020. The Company’s return on average assets was 1.17% for the quarter ended September 30, 2021, compared to 1.03% for the quarter ended June 30, 2021, and 1.03% for the quarter ended...

Continue reading

Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2021 Financial Results on November 4, 2021

Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2021 Financial Results on November 4, 2021

SAN FRANCISCO, Oct. 21, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the third quarter ended September 30, 2021 on Thursday, November 4, 2021. The update will be provided via a press release after market close and will be accessible under Press Releases in the Investors section of the Vir website at www.vir.bio. About Vir BiotechnologyVir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.